TAYD

Taylor Devices, Inc. (TAYD) - Q2 2025 Filing Summary

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended November 30, 2025, and the six-month period ended on the same date. Taylor Devices, Inc. is a smaller reporting company incorporated in New York, specializing in the design and manufacture of precision components for aerospace, defense, structural, and industrial markets. The company operates with a fiscal year ending May 31.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net revenue increased 36% year-over-year (YoY) for the quarter and 7% YoY for the six-month period. The quarterly surge was driven by a 91% increase in revenue from non-long-term projects and a 58% increase in aerospace/defense sales.
• Profitability: Net income rose 90% YoY for the quarter and 13% YoY for the six-month period. Gross margin improved to 47% in the quarter (up from 45% prior year) but was slightly lower at 46% for the six-month period (down from 47% prior year).
• Expense Management: Selling, general, and administrative (SG&A) expenses decreased 4% for the six-month period due to lower incentive compensation accruals, though they rose 6% in the quarter. R&D costs increased significantly (108% in the quarter, 72% for six months) to support new product development.
• Geographic Shift: U.S. sales increased 45% in the quarter and 15% for the six months, while international sales decreased 30% and 32% respectively, reflecting a shift in project mix.
• Working Capital: "Costs and estimated earnings in excess of billings" (CIEB) decreased 55% to $2.42 million, and "Billings in excess of costs" (BIEC) decreased 63% to $1.62 million, indicating normal project billing cycles. Accounts receivable days sales outstanding (DSO) increased from 32 to 40 days.

Outlook, Risks, and Management Commentary

• Backlog: The backlog decreased to $25.1 million from $34.5 million at the prior year-end. Management expects to recognize the majority of this backlog in fiscal years 2026 and 2027.
• Capital Expenditures: CapEx for the six months was $1.49 million, up from $0.97 million in the prior year. The company has commitments of $1.73 million for the next 12 months and is evaluating additional spending to expand capacity.
• Liquidity: The company maintains strong liquidity with $1.96 million in cash and $38.8 million in short-term investments. Operating cash flow for the six months was positive at $6.23 million.
• Risks: Key risks include reductions in customer capital budgets, changing product demand, increased competition, and technological obsolescence. The company notes that results for interim periods are not necessarily indicative of full-year results.
• Accounting Updates: The company is evaluating the impact of new FASB standards regarding income tax disclosures (ASU 2023-09) and expense disaggregation (ASU 2024-03).

Investor Verification Checklist

• Backlog Conversion: Verify the timeline for converting the $25.1 million backlog into revenue, noting the decrease from the prior year's $34.5 million.
• DSO Trend: Monitor the increase in Days Sales Outstanding (40 days vs. 32 days) to ensure collection efficiency remains stable.
• R&D Sustainability: Assess whether the sharp increase in R&D spending (108% YoY in Q2) is a one-time investment or a new baseline for operating expenses.
• Geographic Concentration: Confirm the sustainability of the shift toward U.S. sales (94% of Q2 revenue) given the significant drop in international sales.
• Inventory Obsolescence: Review the $145,000 provision for inventory obsolescence recorded in the six-month period and the composition of maintenance inventory.